Robert Frantz
Overview
Explore the profile of Robert Frantz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
976
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dardi F, Boucly A, Benza R, Frantz R, Mercurio V, Olschewski H, et al.
Eur Respir J
. 2024 Aug;
64(4).
PMID: 39209472
Risk stratification has gained an increasing role in predicting outcomes and guiding the treatment of patients with pulmonary arterial hypertension (PAH). The most predictive prognostic factors are three noninvasive parameters...
2.
Tello K, Yogeswaran A, Majeed R, Kiely D, Lawrie A, Brittain E, et al.
Chest
. 2024 Aug;
167(1):224-240.
PMID: 39182575
Background: Patients with COPD frequently demonstrate pulmonary hypertension (PH). Severe PH in patients with COPD, identified by pulmonary vascular resistance (PVR) of > 5 Wood units (WU), is closely linked...
3.
Yogeswaran A, Gall H, Funderich M, Wilkins M, Howard L, Kiely D, et al.
Chest
. 2024 Mar;
166(3):585-603.
PMID: 38508334
Background: Pulmonary hypertension (PH) is a heterogeneous disease with a poor prognosis. Accurate risk stratification is essential for guiding treatment decisions in pulmonary arterial hypertension (PAH). Although various risk models...
4.
Naranjo M, Rosenzweig E, Hemnes A, Jacob M, Desai A, Hill N, et al.
Pulm Circ
. 2023 Aug;
13(3):e12281.
PMID: 37614830
The prevalence of acute vasodilator response (AVR) to inhaled nitric oxide (iNO) during right heart catheterization (RHC) is 12% in idiopathic pulmonary arterial hypertension (IPAH). AVR, however, is reportedly lower...
5.
Forfia P, Benza R, DAlto M, De Marco T, Elwing J, Frantz R, et al.
Pulm Circ
. 2023 May;
13(2):e12240.
PMID: 37222992
Right heart (RH) structure and function are major determinants of symptoms and prognosis in pulmonary arterial hypertension (PAH). RH imaging provides detailed information, but evidence and guidelines on the use...
6.
McGlothlin D, Granton J, Klepetko W, Beghetti M, Rosenzweig E, Corris P, et al.
J Heart Lung Transplant
. 2022 Sep;
41(9):1135-1194.
PMID: 36123001
Pulmonary hypertension (PH) is a risk factor for morbidity and mortality in patients undergoing surgery and anesthesia. This document represents the first international consensus statement for the perioperative management of...
7.
Majeed R, Wilkins M, Howard L, Hassoun P, Anthi A, Cajigas H, et al.
Pulm Circ
. 2022 Aug;
12(3):e12123.
PMID: 36034404
The Pulmonary Vascular Research Institute GoDeep meta-registry is a collaboration of pulmonary hypertension (PH) reference centers across the globe. Merging worldwide PH data in a central meta-registry to allow advanced...
8.
Schettle S, Frantz R, Stulak J, Villavicencio M, Rosenbaum A
Mayo Clin Proc
. 2022 Jul;
97(7):1399-1401.
PMID: 35787869
No abstract available.
9.
Guy C, Schoch B, Frantz R, Wright T, Struk A, Farmer K, et al.
JSES Int
. 2022 Mar;
6(2):229-235.
PMID: 35252918
Background: Reverse total shoulder arthroplasty (RTSA) is a procedure growing in prevalence among younger populations. Consequently, its use in revision arthroplasty is growing in this demographic. However, studies examining the...
10.
Frantz R, Chukwuma O, Sokumbi O, Satcher K, Kallis P, Vincek V, et al.
J Cutan Pathol
. 2021 Dec;
49(3):323-326.
PMID: 34939211
No abstract available.